• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在缺血预处理的触发阶段,STAT-3和Akt的双重激活是必需的。

Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning.

作者信息

Suleman Naushaad, Somers Sarin, Smith Robert, Opie Lionel H, Lecour Sandrine C

机构信息

Hatter Cardiovascular Research Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Private Bag 3, 7935 Observatory, South Africa.

出版信息

Cardiovasc Res. 2008 Jul 1;79(1):127-33. doi: 10.1093/cvr/cvn067. Epub 2008 Mar 13.

DOI:10.1093/cvr/cvn067
PMID:18339648
Abstract

AIMS

During preconditioning by tumour necrosis factor-alpha (TNFalpha), activation of the signal transducer and activator of transcription-3 (STAT-3) but not Akt, is essential, whereas ischaemic cardiac preconditioning (IPC) requires both STAT-3 and Akt at the time of reperfusion. However, it is not known whether the same signalling pattern occurs during the preconditioning stimulus (trigger phase) and whether links exist between STAT-3 and Akt. Hence, our hypothesis is that concomitant activation or co-interaction between these two key signals is required during the trigger phase for IPC. Conversely, we proposed that there would be no such interaction when preconditioning was induced by TNFalpha (TNF-PC).

METHODS AND RESULTS

Cardiomyocytes, isolated from adult wild-type (WT) and cardiac-specific STAT-3 knockout (KO) mice, were exposed to simulated ischaemia (SI) reperfusion. Cells were preconditioned either by 30 min SI or by 30 min TNFalpha (0.5 ng/mL) in the presence or absence of AG490 (100 nM) or wortmannin (100 nM) to inhibit STAT-3 or Akt, respectively. Cell viability was evaluated by trypan blue, and phosphorylation levels of STAT-3 and Akt were measured by Western blot analysis. Similar experiments were conducted in isolated rat hearts subjected to an ischaemia-reperfusion insult. Both preconditioning stimuli failed to protect KO cardiomyocytes, and addition of AG490 abolished preconditioning in WT cardiomyocytes or isolated hearts. Wortmannin abolished the protection afforded by IPC, but did not affect TNF-PC in both models. Western blot analysis demonstrated that added wortmannin during IPC stimulus decreased STAT-3 phosphorylation while, conversely, AG490 reduced Akt phosphorylation.

CONCLUSION

STAT-3 activation could be achieved independent of Akt during TNF-PC. In contrast, during an IPC stimulus, both prosurvival signalling molecule cascades acted in concert so that inhibiting activation of STAT-3 also inhibited that of Akt and vice versa.

摘要

目的

在肿瘤坏死因子-α(TNFα)预处理过程中,信号转导及转录激活因子3(STAT-3)而非Akt的激活至关重要,而缺血性心脏预处理(IPC)在再灌注时需要STAT-3和Akt两者。然而,尚不清楚在预处理刺激(触发阶段)期间是否出现相同的信号传导模式,以及STAT-3和Akt之间是否存在联系。因此,我们的假设是,在IPC的触发阶段需要这两个关键信号的同时激活或共同相互作用。相反,我们提出,当由TNFα诱导预处理(TNF-PC)时不会有这种相互作用。

方法与结果

从成年野生型(WT)和心脏特异性STAT-3基因敲除(KO)小鼠分离的心肌细胞,暴露于模拟缺血(SI)再灌注。细胞分别通过30分钟SI或30分钟TNFα(0.5 ng/mL)进行预处理,存在或不存在AG490(100 nM)或渥曼青霉素(100 nM)以分别抑制STAT-3或Akt。通过台盼蓝评估细胞活力,并通过蛋白质印迹分析测量STAT-3和Akt的磷酸化水平。在遭受缺血-再灌注损伤的离体大鼠心脏中进行了类似实验。两种预处理刺激均未能保护KO心肌细胞,并且添加AG490消除了WT心肌细胞或离体心脏中的预处理。渥曼青霉素消除了IPC提供的保护,但在两种模型中均不影响TNF-PC。蛋白质印迹分析表明,在IPC刺激期间添加渥曼青霉素会降低STAT-3磷酸化,相反,AG490会降低Akt磷酸化。

结论

在TNF-PC期间,STAT-3的激活可以独立于Akt实现。相反,在IPC刺激期间,两种促生存信号分子级联协同作用,因此抑制STAT-3的激活也会抑制Akt的激活反之亦然。

相似文献

1
Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning.在缺血预处理的触发阶段,STAT-3和Akt的双重激活是必需的。
Cardiovasc Res. 2008 Jul 1;79(1):127-33. doi: 10.1093/cvr/cvn067. Epub 2008 Mar 13.
2
Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).用肿瘤坏死因子-α进行药理预处理可在再灌注时激活信号转导和转录激活因子-3,且不涉及经典的促存活激酶(Akt和细胞外信号调节激酶)。
Circulation. 2005 Dec 20;112(25):3911-8. doi: 10.1161/CIRCULATIONAHA.105.581058. Epub 2005 Dec 12.
3
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.缺血后处理通过SAFE通路预防再灌注损伤。
Cardiovasc Res. 2009 Nov 1;84(2):201-8. doi: 10.1093/cvr/cvp274. Epub 2009 Aug 7.
4
Role of STAT3 in ischemic preconditioning.信号转导和转录激活因子3(STAT3)在缺血预处理中的作用。
J Mol Cell Cardiol. 2001 Nov;33(11):1929-36. doi: 10.1006/jmcc.2001.1456.
5
Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning.心肌细胞信号转导与转录激活因子3(STAT-3)的基因缺失消除了经典预处理。
Cardiovasc Res. 2004 Sep 1;63(4):611-6. doi: 10.1016/j.cardiores.2004.06.019.
6
Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.缺血预处理中的激酶和磷酸酶:再评价。
Basic Res Cardiol. 2010 Jul;105(4):495-511. doi: 10.1007/s00395-010-0086-3. Epub 2010 Feb 2.
7
Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.肿瘤坏死因子-α 对未处理的心肌缺血/再灌注损伤无调节作用,但对延迟预处理的形成至关重要。
J Mol Cell Cardiol. 2004 Jul;37(1):51-61. doi: 10.1016/j.yjmcc.2004.03.012.
8
Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation.缺血后适应通过激活鞘氨醇激酶同工型-1保护离体小鼠心脏免受缺血/再灌注损伤。
Cardiovasc Res. 2008 Jul 1;79(1):134-40. doi: 10.1093/cvr/cvn065. Epub 2008 Mar 11.
9
TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning.在经典缺血预处理的体内模型中,肿瘤坏死因子α(TNFα)是赋予保护作用所必需的。
Life Sci. 2007 Apr 10;80(18):1686-91. doi: 10.1016/j.lfs.2007.01.040. Epub 2007 Jan 30.
10
Ethanolamine is a novel STAT-3 dependent cardioprotective agent.乙醇胺是一种新型依赖 STAT-3 的心脏保护剂。
Basic Res Cardiol. 2010 Nov;105(6):763-70. doi: 10.1007/s00395-010-0125-0. Epub 2010 Oct 12.

引用本文的文献

1
Serpina3k lactylation protects from cardiac ischemia reperfusion injury.丝氨酸蛋白酶抑制剂A3K(Serpina3k)乳酸化可保护心脏免受缺血再灌注损伤。
Nat Commun. 2025 Jan 25;16(1):1012. doi: 10.1038/s41467-024-55589-w.
2
Blockage of PHLPP1 protects against myocardial ischemia/reperfusion injury in diabetic mice via activation of STAT3 signaling.阻断PHLPP1可通过激活STAT3信号通路保护糖尿病小鼠免受心肌缺血/再灌注损伤。
J Bioenerg Biomembr. 2023 Oct;55(5):325-339. doi: 10.1007/s10863-023-09977-4. Epub 2023 Aug 16.
3
Effects of Iron Nanoparticles Administration on Ischemia/Reperfusion Injury in Isolated Hearts of Male Wistar Rats.
铁纳米粒子给药对雄性 Wistar 大鼠离体心脏缺血/再灌注损伤的影响。
Physiol Res. 2023 Jun 9;72(S1):S61-S72. doi: 10.33549/physiolres.935112.
4
Intralipid® improves left ventricular function in rats with lipopolysaccharide-induced endotoxaemia by a Src-STAT3-mediated mechanism.英脱利匹特®通过Src-STAT3介导的机制改善脂多糖诱导的内毒素血症大鼠的左心室功能。
Br J Anaesth. 2023 Feb;130(2):e183-e187. doi: 10.1016/j.bja.2022.10.019. Epub 2022 Dec 1.
5
Role of nuclear factor kappa-B in TNF-induced cytoprotection.核因子 κB 在 TNF 诱导的细胞保护中的作用。
Cardiovasc J Afr. 2023;34(2):74-80. doi: 10.5830/CVJA-2022-023. Epub 2022 Jun 8.
6
Cardiomyocyte IL-1R2 protects heart from ischemia/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis.心肌细胞白介素-1 受体 2 通过减弱白介素-17A 受体介导致心肌细胞凋亡来保护心脏免受缺血/再灌注损伤。
Cell Death Dis. 2022 Jan 27;13(1):90. doi: 10.1038/s41419-022-04533-1.
7
SOCS3 deficiency in cardiomyocytes elevates sensitivity of ischemic preconditioning that synergistically ameliorates myocardial ischemia reperfusion injury.心肌细胞中 SOCS3 的缺失会提高缺血预处理的敏感性,从而协同改善心肌缺血再灌注损伤。
PLoS One. 2021 Jul 22;16(7):e0254712. doi: 10.1371/journal.pone.0254712. eCollection 2021.
8
The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.肾素抑制剂在 ST 段抬高型心肌梗死心肌缺血再灌注损伤预防中的作用机制。
Cells. 2020 Sep 21;9(9):2134. doi: 10.3390/cells9092134.
9
An Update on the Multifaceted Roles of STAT3 in the Heart.信号转导与转录激活因子3(STAT3)在心脏中的多方面作用的最新进展
Front Cardiovasc Med. 2019 Oct 25;6:150. doi: 10.3389/fcvm.2019.00150. eCollection 2019.
10
Preconditioning in cardiac anesthesia…… where are we?心脏麻醉中的预处理……我们进展到哪一步了?
Ann Card Anaesth. 2019 Oct-Dec;22(4):412-421. doi: 10.4103/aca.ACA_116_18.